Virtual Rehab Improved Walking in HCT Survivors—With Limits

A virtual rehabilitation program improved walking capacity in selected long-term hematopoietic cell transplant (HCT) survivors, but it did not improve hand-grip strength or quality of life. The distinction matters. Better performance on a walking test can make daily activity easier; it does not automatically mean that a survivor feels better overall.

In a 2025 multicenter randomized trial, the program produced a 51.4-meter greater gain in 6-minute walk distance at 3 months than usual care (95% CI, 27.3 to 75.5), rising to 59.3 meters at 12 months. Those effects met or slightly exceeded the trial's stated 50-meter threshold for clinical significance. This is useful oncology-rehabilitation evidence, not a general prescription for anyone seeking a remote exercise-and-mindfulness upgrade.

A year-long functional signal in transplant survivors

The randomized trial by David D. Ma et al. assigned 139 long-term HCT survivors 1:1 to the virtual program or usual care. Its primary endpoint was 6-minute walk distance, an objective measure of how far a person can walk in six minutes. Compared with usual care, participants assigned to the intervention improved by 51.4 meters at 3 months and 59.3 meters at 12 months. The reported effect sizes were 0.52 and 0.60, respectively.

The intervention group also improved on sit-to-stand performance at 3 and 12 months relative to usual care. That supports a broader effect on physical function rather than a one-test fluke. The paper cites a change of at least two sit-to-stand repetitions as clinically meaningful, but the available report does not provide the exact between-group estimate for that outcome. It would be a mistake to fill in that blank with confidence.

Hand-grip strength and quality-of-life outcomes did not show significant between-group improvement. That result narrows the conclusion: the package improved selected measures of physical performance, not every measure of strength or recovery.

What participants actually received

This was more structured than generic encouragement to move more. Participants attended a one-time, half-day in-person orientation, then completed a six-week individualized home program. Aerobic exercise targeted 50% to 75% of predicted heart-rate reserve. Resistance work targeted 65% to 80% of one-repetition maximum. The prescribed volume was 30 to 40 minutes three times weekly, or an equivalent amount.

Exercise came bundled with stress education and mindfulness practice. Participants had weekly one-hour one-on-one telehealth sessions for six weeks, followed by three monthly half-hour motivational sessions between months 3 and 6. The investigators reported no intervention-related adverse events.

The study also found a significant between-group change in soluble intercellular adhesion molecule-1 (sICAM-1). This biomarker finding remains exploratory: the reported information does not provide its effect magnitude, confidence interval, or a multiplicity-adjusted interpretation. A biomarker shift is not proof that the intervention changed a disease mechanism or improved clinical outcomes.

Why the result deserves attention

Randomization gives this study more weight than an uncontrolled before-and-after program. The researchers used an objective primary endpoint, analyzed participants by intention to treat, and followed them to 12 months rather than ending assessment when the active six-week program ended. Follow-up completion was 92% at 3 months, 87% at 6 months, and 74.8% at 12 months.

The result also fits a larger research question: can transplant recipients preserve or rebuild function through organized exercise and remote support? A 2022 randomized trial in pediatric stem-cell transplantation tested exercise during transplantation, while a 2026 randomized trial of telematic follow-up after hematological transplantation examined remote support for physical activity. These studies involve different populations and settings, so they cannot confirm the Ma trial's effect size. They do show that rehabilitation is an active clinical research area rather than a wellness add-on wearing a lab coat.

Evidence from other transplant populations points in the same general direction, with important limits. In kidney transplant recipients, a small 2021 randomized resistance-training trial assigned only 16 people and assessed physical performance and health-related quality of life after 10 weeks. In liver transplantation, a 2022 systematic review of prehabilitation found a developing but mixed evidence base; six of its eight included studies were rated low quality by GRADE. Similar questions do not create interchangeable answers.

What the trial cannot tell us

The program bundled exercise, mindfulness or stress management, telehealth supervision, and motivational boosters. The trial therefore cannot identify which component caused the walking benefit. Exercise may have driven most of the effect; coaching contact, stress-management content, or the combination may also have mattered. A randomized trial protocol for the PRISM resilience intervention shows that psychosocial support is being tested in HCT populations, but it does not establish that mindfulness added benefit in this program.

The participants were also relatively selected. Eligible survivors were 18 to 75 years old, with a median age of 58 and a median of 21 months since transplant. The study excluded people with severe graft-versus-host disease, exercise-limiting cardiovascular disease, incapacitating psychological illness, active medical illness, or Hospital Anxiety and Depression Scale scores of 15 or higher. These exclusions improve safety and interpretability, but they limit applicability to people who are medically unstable, highly distressed, or unable to use a digitally supported program.

The trial supports a specific claim: a supervised, multicomponent remote program improved objective physical performance in selected long-term HCT survivors. It does not establish the best program design or prove a quality-of-life benefit.

Enrollment also stopped below target. The investigators planned for 160 participants but stopped at 140 because of slow accrual and funding limits; 139 were randomized. By 12 months, 104 participants remained, meaning attrition reached 25.2%. Intention-to-treat analysis helps, but missing follow-up data still make the long-term estimate less certain. The publication does not make the exact missing-data model or long-term adherence after the active phase clear enough to explain why the effect persisted.

Function and lived recovery are separate outcomes

The lack of a quality-of-life signal is not a technical footnote. It means that a measurable improvement in walking did not translate into a significant between-group improvement in the quality-of-life outcomes assessed by this trial. Long-term transplant survivorship includes symptoms, emotional health, practical burdens, and social functioning that a 6-minute walk test cannot capture.

That broader perspective appears in 2023 research on patient-reported outcomes among long-term autologous HCT survivors with multiple myeloma, which describes persistent symptom burden and complex health-related quality-of-life trajectories. The population differs from the Ma trial, but the lesson travels: performance metrics and patient experience answer different questions.

The verdict

This trial provides credible evidence that a structured virtual exercise and stress-management program can improve 6-minute walk distance, and likely other aspects of lower-body functional performance, in selected long-term HCT survivors. The 51.4-meter advantage at 3 months had a confidence interval entirely above zero, and the 59.3-meter difference at 12 months met the study's own threshold for clinical importance.

It does not show that mindfulness was necessary, that telehealth alone produced the result, or that the program improved grip strength, quality of life, complications, or survival. Before clinics treat this as routine survivorship care, the field needs replication in broader survivor groups, trials that separate exercise from contact and stress-management effects, and outcomes that connect better physical performance to day-to-day recovery.